NIOSHTIC-2 Publications Search

Enhancement of butylated hydroxytoluene-induced mouse lung damage by butylated hydroxyanisole.

Authors
Thompson-DC; Trush-MA
Source
Toxicol Appl Pharmacol 1988 Oct; 96(1):115-121
NIOSHTIC No.
00184499
Abstract
A study of the enhancement of butylated-hydroxytoluene (128370) (BHT) induced mouse lung damage by butylated-hydroxyanisole (25013165) (BHA) was presented. Male CD-1-mice treated with intraperitoneal injections of BHT at 250 to 500mg/kg had significantly elevated lung to body weight ratio (LBR) 4 days after treatment. BHA given subcutaneously (SC) at 100 to 500mg/kg did not alter the LBR. BHT did not significantly alter LBR at a concentration of 175mg/kg but mice pretreated with BHA at 50 or 250mg/kg 30 minutes prior to the BHT had an enhanced LBR. Toxicity was enhanced by doses of BHA ranging from 50 to 250mg/kg when given 30 minutes prior to BHT 250mg/kg. BHA was effective when given simultaneous with or up to 4 hours prior to BHT. When given after BHT, or when given intraperitoneally, BHA had no effect. Deuteration of BHT prevented the BHA enhanced BHT induced increases in LBR. The authors conclude that BHA can reduce the threshold for BHT induced lung toxicity and that interactions of other antioxidants should be examined.
Keywords
NIOSH-Publication; NIOSH-Grant; Cancer; In-vivo-studies; Laboratory-animals; Lung-tissue; Pulmonary-system-disorders; Synergism; Food-additives; Metabolic-study; Toxic-effects
CODEN
TXAPA9
CAS No.
128-37-0; 25013-16-5
Publication Date
19881001
Document Type
Journal Article
Funding Amount
36409
Funding Type
Grant
Fiscal Year
1989
Identifying No.
Grant-Number-R01-OH-01833
Issue of Publication
1
ISSN
0041-008X
Priority Area
Pulmonary-system-disorders
Source Name
Toxicology and Applied Pharmacology
State
MD
Performing Organization
Johns Hopkins University
Page last reviewed: April 12, 2019
Content source: National Institute for Occupational Safety and Health Education and Information Division